Cart (0 Items)
Your cart is currently empty.
View ProductsBrand | ProteoGenix |
---|---|
Product type | Elisa assay kits |
Size | 96T |
Product name | Tovetumab ELISA Kit |
---|---|
Delivery condition | Blue ice (+4°) |
Storage condition | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
Brand | ProteoGenix |
Size | 96T |
Reference | KPTX194 |
Note | For research use only. |
Sample type | Plasma, Serum |
Immunogen | Tovetumab |
Introduction to Tovetumab ELISA Kit
Tovetumab, also known as PF-06380101, is a novel monoclonal antibody that has shown promising results in pre-clinical studies as a potential therapeutic target for various types of cancer. The development and characterization of Tovetumab has led to the creation of a specific ELISA kit for its detection and quantification, making it a valuable tool for researchers and clinicians. In this article, we will provide a detailed description of the structure, activity, and application of the Tovetumab ELISA Kit.
Structure of Tovetumab ELISA Kit
The Tovetumab ELISA Kit is composed of several components, including microplates coated with a specific antibody against Tovetumab, standards, and controls. The microplates are made of high-quality polystyrene and have a 96-well format, allowing for the simultaneous analysis of multiple samples. The antibody used in the kit is highly specific for Tovetumab, ensuring accurate and reliable results.
Activity of Tovetumab ELISA Kit
The Tovetumab ELISA Kit utilizes the principle of enzyme-linked immunosorbent assay (ELISA) to detect and quantify Tovetumab in biological samples. The assay is based on the specific binding of Tovetumab to the antibody coated on the microplate. The samples, along with the standards and controls, are added to the microplate and allowed to incubate. During this incubation, Tovetumab in the sample binds to the antibody, forming an antigen-antibody complex.
After washing away any unbound components, a secondary antibody conjugated to an enzyme is added to the microplate. This secondary antibody recognizes and binds to the antigen-antibody complex, resulting in the formation of a sandwich complex. The enzyme attached to the secondary antibody catalyzes a color-producing reaction, which is directly proportional to the amount of Tovetumab present in the sample. The color intensity is measured using a spectrophotometer, and the concentration of Tovetumab in the sample is determined by comparing it to the standard curve.
Application of Tovetumab ELISA Kit
The Tovetumab ELISA Kit has a wide range of applications in research and clinical settings. It can be used to detect and quantify Tovetumab in various biological samples, including serum, plasma, and cell culture supernatants. This makes it a valuable tool for monitoring the levels of Tovetumab in patients undergoing treatment with this antibody.
Additionally, the Tovetumab ELISA Kit can also be used in pre-clinical studies to evaluate the pharmacokinetics and pharmacodynamics of Tovetumab. By measuring the concentration of Tovetumab in different tissues and body fluids, researchers can gain insights into its distribution, metabolism, and elimination from the body.
Furthermore, the Tovetumab ELISA Kit can be used to screen potential therapeutic candidates that target Tovetumab. By measuring the ability of these candidates to inhibit the binding of Tovetumab to its target, researchers can identify potential drugs that may enhance the efficacy of Tovetumab in cancer treatment.
Conclusion
In summary, the Tovetumab ELISA Kit is a valuable tool for the detection and quantification of Tovetumab in biological samples. Its specific and sensitive assay allows for accurate and reliable measurement of Tovetumab levels, making it an essential tool for researchers and clinicians working with this novel therapeutic target. With its wide range of applications, the Tovetumab ELISA Kit is a valuable addition to the arsenal of tools available for studying and developing Tovetumab as a potential treatment for cancer.
Send us a message from the form below
Reviews
There are no reviews yet.